# IS-002 Phase 2 Prostate Cancer Study

> **NCT05946603** · PHASE2 · COMPLETED · sponsor: **Intuitive Surgical** · enrollment: 59 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Administration of IS-002
- **DEVICE:** Firefly fluorescent imaging
- **PROCEDURE:** robotic-assisted laparoscopic prostatectomy with pelvic lymph node dissection

## Key facts

- **NCT ID:** NCT05946603
- **Lead sponsor:** Intuitive Surgical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-16
- **Primary completion:** 2024-05-21
- **Final completion:** 2025-05-23
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05946603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05946603, "IS-002 Phase 2 Prostate Cancer Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05946603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*